Gene Predictis is a Swiss company dedicated to personalized medicine. Our main objective is the development of innovative diagnostic tools based on genetics that allow tailored treatments for patients. Our products enable to improve drug treatment efficacy and/or significantly reduce harmful side effects resulting from adverse drug reactions. We also develop genetic tests that help to establish predictive diagnosis, paving the way to a highly personalised medical advice.
The company was founded in 2005 and the laboratory facilities were opened in September 2007. The panels of the services we offer are all based on DNA/RNA technologies.
Gene Predictis is based at EPFL Innovation Park (École Polytechnique Fédérale de Lausanne) in Lausanne, Switzerland, and aims to become the reference company in personalized medicine, notably concerning personalized drug prescription.